Влияние ожирения на половой диморфизм уровней ирисина

Проведен сравнительный анализ средних уровней ирисина между женщинами и мужчинами (с нормальным весом и ожирением) для оценки полового диморфизма. В исследованной нами выборке якутов половой диморфизм обнаружен в группе лиц с нормальным весом: уровни ирисина были значимо выше у женщин по сравнению с мужчинами. Сравнительный анализ уровней ирисина в расширенной выборке обнаружил статистически значимый половой диморфизм только в группе лиц с ожирением, в группе лиц с нормальным весом половых отличий не было обнаружено. Таким образом, выявлено влияние ожирения на половой диморфизм.

1. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis / Boström P., Wu J., Jedrychowski M.P. [et al.] // Nature. 2012: 7382(481): 463-468. doi:10.1038/nature10777

2. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women / Kraemer R.R., Shockett P., Webb N.D. [et al.] //Hormone and metabolic research. 2014. 46(2): 150-154.

3. Adipose Tissue Secretion Pattern Influences β-Cell Wellness in the Transition from Obesity to Type 2 Diabetes / Biondi G., Marrano N., Borrelli A. [et al.] //International Journal of Molecular Sciences. 2022. 23(10): 5522.

4. Association between serum irisin levels and non-alcoholic fatty liver disease in health screen examinees / Choi E.S., Kim M.K., Song M.K. [et al.] // PloS one. 2014. 9(10): e110680.

5. Association of circulating irisin and cardiopulmonary exercise capacity in healthy volunteers: results of the Study of Health in Pomerania / Kerstholt N., Ewert R., Nauck M. [et al.] // BMC pulmonary medicine. 2015. 15(1): 1-9.

6. Association of plasma irisin with bone mineral density in a large Chinese population using an extreme sampling design / Wu L.F., Zhu D.C., Tang C.H. [et al.] //Calcified tissue international. 2018. 103(3): 246-251.

7. Association of serum irisin with metabolic syndrome in obese Chinese adults / Yan B., Shi X., Zhang H. [et al.] //PloS one. 2014. 9(4): e94235.

8. Biological Response of Irisin Induced by Different Types of Exercise in Obese Subjects: A Non-Inferiority Controlled Randomized Study / D’Amuri A., Raparelli V., Sanz J.M. [et al.] // Biology. 2022. 11(3): 392.

9. Christensen A.A., Gannon M. The beta cell in type 2 diabetes //Current diabetes reports. 2019. 19(9): 1-8.

10. Circulating irisin concentrations are associated with a favourable lipid profile in the general population / Oelmann S., Nauck M., Völzke H. et al. //PloS one. 2016. 11(4): e0154319.

11. Circulating irisin in healthy adults: Changes after acute exercise, correlation with body composition, and energy expenditure parameters in cross-sectional study / Lagzdina R., Rumaka M., Gersone G., et al. //Medicina. 2020. 56(6): 274.

12. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition / Anastasilakis A.D., Polyzos S.A., Saridakis Z.G. [et al.] // The Journal of Clinical Endocrinology & Metabolism. 2014: 99(9): 3247-3255. doi:10.1210/jc.2014-1367

13. Circulating irisin in relation to insulin resistance and the metabolic syndrome / Park K., Zaichenko L., Brinkoetter M. [et al.] //The journal of clinical endocrinology & metabolism. 2013. 98(12): 4899-4907.

14. Circulating irisin is reduced in male patients with type 1 and type 2 myotonic dystrophies / Dozio E., Passeri E., Cardani R. [et al.] // Frontiers in endocrinology. 2017. 8: 320.

15. Circulating irisin levels in response to acute and chronic exercise in obese adults / Winn N.C., Liu Y., Heden T.D. [et al.] //International Journal of Exercise Science: Conference Proceedings. 2013. 11(1): 42.

16. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-Correlation with body mass index / Stengel A., Hofmann T., Goebel-Stengel M. [et al.] // Peptides. 2013. 39: 125-130.

17. Circulating sclerostin and irisin are related and interact with gender to influence adiposity in adults with prediabetes / Klangjareonchai T., Nimitphong H., Saetung S. [et al.] //International Journal of Endocrinology. 2014. 2014.

18. Circulating serum irisin levels in obesity and type 2 diabetes mellitus / Shoukry A., Shalaby S.M., El-Arabi Bdeer S. [et al] //IUBMB life. 2016. 68(7): 544-556.

19. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: In vivo and in vitro studies. / Kurdiova T., Balaz M., Vician M. [et al.] //J. Physiol. 2014. 592: 1091– 1107. doi: 10.1113/jphysiol.2013.264655.

20. Effects of swimming exercise on serum irisin and bone FNDC5 in rat models of high-fat diet-induced osteoporosis / Kang Y.S., Kim J.C., Kim J.S. [et al.] //Journal of sports science & medicine. 2019. 18(4): 596.

21. Espes D., Lau J., Carlsson P.O. Increased levels of irisin in people with long-standing Type 1 diabetes //Diabetic medicine. 2015. 32(9): 1172-1176.

22. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure / Lecker S.H., Zavin A., Cao P., [et al.] //Circulation: Heart Failure. 2012. 5(6): 812-818.

23. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise / Huh J.Y., Panagiotou G., Mougios V. [et al.] // Metabolism. 2012: 61(12): 1725-1738. doi:10.1016/j.metabol.2012.09.002

24. FNDC5/irisin is not only a myokine but also an adipokine / Roca-Rivada A., Castelao C., Senin L.L. [et al.] // PloS one. 2013: 8(4): e60563. doi:10.1371/journal.pone.0060563

25. FNDC5: a novel player in metabolism and metabolic syndrome / Cao R.Y., Zheng H., Redfearn D. [et al.] //Biochimie. 2019. 158: 111-116.

26. Geer E.B., Shen W. Gender differences in insulin resistance, body composition, and energy balance //Gender medicine. 2009. 6: 60-75.

27. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects / Sesti G., Andreozzi F., Fiorentino T.V. [et al.] //Acta diabetologica. 2014. 51(5): 705-713.

28. Increased FNDC 5 is associated with insulin resistance in high fat-fed mice / Guilford B.L., Parson J.C., Grote C.W. [et al.] //Physiological reports. 2017. 5(13): e13319.

29. International Obesity Task Force. Obesity: Managing the Global Epidemic: Report of the World Health Organization (WHO) Consultation; World Health Organization: Geneva, Switzerland, 1997.

30. Irisin and exercise training in humans–results from a randomized controlled training trial / Hecksteden A., Wegmann M., Steffen A. [et al.] //BMC medicine. 2013. 11(1): 1-8.

31. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: a cross sectional and a prospective case-control study nested in the Normative Aging Study / Sahin-Efe A., Upadhyay J., Ko B.J. [et al.] //Metabolism. 2018. 79: С. 24-32.

32. Irisin and markers of metabolic derangement in non-diabetic Caucasian subjects with stage I-II obesity during early aging / Campolo J., Corradi E., Rizzardi A. [et al.] // PloS one. 2020. 15(2): e0229152.

33. Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise / Brenmoehl J., Albrecht E., Komolka K. [et al] //International journal of biological sciences. 2014. 10(3): 338.

34. Sex-Dependent Association between Circulating Irisin Levels and Insulin Resistance in Healthy Adults / Jameel F., Thota R.N., Wood L.G. [et al.] // Journal of Nutrition & Intermediary Metabolism. 2015. 2(3): 86–92. https://doi.org/10.1016/j.jnim.2015.10.001.

35. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews / Page M.J., McKenzie J.E., Bossuyt P.M. [et al.] // Systematic reviews. 2021. 10(1): 1-11.